Literature DB >> 25112892

The appropriate use of neurostimulation: new and evolving neurostimulation therapies and applicable treatment for chronic pain and selected disease states. Neuromodulation Appropriateness Consensus Committee.

Timothy R Deer1, Elliot Krames, Nagy Mekhail, Jason Pope, Michael Leong, Michael Stanton-Hicks, Stan Golovac, Leo Kapural, Ken Alo, Jack Anderson, Robert D Foreman, David Caraway, Samer Narouze, Bengt Linderoth, Asokumar Buvanendran, Claudio Feler, Lawrence Poree, Paul Lynch, Tory McJunkin, Ted Swing, Peter Staats, Liong Liem, Kayode Williams.   

Abstract

INTRODUCTION: The International Neuromodulation Society (INS) has determined that there is a need to provide an expert consensus that defines the appropriate use of neuromodulation technologies for appropriate patients. The Neuromodulation Appropriateness Consensus Committee (NACC) was formed to give guidance to current practice and insight into future developments.
METHODS: The INS executive board selected members of the international scientific community to analyze scientific evidence for current and future innovations and to use clinical experience to fill in any gaps in information. The NACC used PubMed and Google Scholar to obtain current evidence in the field and used clinical and research experience to give a more complete picture of the innovations in the field.
RESULTS: The NACC has determined that currently approved neurostimulation techniques and technologies have expanded our ability to treat patients in a more effective and specific fashion. Despite these advances, the NACC has identified several additional promising technologies and potential applications for neurostimulation that could move this field forward and expand the applicability of neuromodulation.
CONCLUSIONS: The NACC concludes that the field of neurostimulation is an evolving and rapidly changing one that will lead to improved patient access, safety, and outcomes.
© 2014 International Neuromodulation Society.

Entities:  

Keywords:  Cerebellar stimulation; chronic pain; functional electrical stimulation; nanotechnology; neurostimulation; optogenetics; platelet-rich plasma; regenerative medicine; sphenopalatine ganglion stimulation; spinal cord stimulation; telemedicine

Mesh:

Year:  2014        PMID: 25112892     DOI: 10.1111/ner.12204

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  22 in total

Review 1.  Spinal Cord Stimulation for Pain Treatment After Spinal Cord Injury.

Authors:  Qian Huang; Wanru Duan; Eellan Sivanesan; Shuguang Liu; Fei Yang; Zhiyong Chen; Neil C Ford; Xueming Chen; Yun Guan
Journal:  Neurosci Bull       Date:  2018-12-17       Impact factor: 5.203

2.  Neuro-Nano Interfaces: Utilizing Nano-Coatings and Nanoparticles to Enable Next-Generation Electrophysiological Recording, Neural Stimulation, and Biochemical Modulation.

Authors:  Ashlyn T Young; Neil Cornwell; Michael A Daniele
Journal:  Adv Funct Mater       Date:  2017-06-07       Impact factor: 18.808

Review 3.  Neuropathic pain.

Authors:  Luana Colloca; Taylor Ludman; Didier Bouhassira; Ralf Baron; Anthony H Dickenson; David Yarnitsky; Roy Freeman; Andrea Truini; Nadine Attal; Nanna B Finnerup; Christopher Eccleston; Eija Kalso; David L Bennett; Robert H Dworkin; Srinivasa N Raja
Journal:  Nat Rev Dis Primers       Date:  2017-02-16       Impact factor: 52.329

4.  Evaluation of Sagittal Spinopelvic Balance in Spinal Cord Stimulator Patients.

Authors:  Royce W Woodroffe; Eli A Perez; Scott C Seaman; Brian J Park; Russ P Nockels; Matthew A Howard; Saul Wilson
Journal:  Neuromodulation       Date:  2021-06-09

Review 5.  Spinal Cord Stimulation: Clinical Efficacy and Potential Mechanisms.

Authors:  Andrei D Sdrulla; Yun Guan; Srinivasa N Raja
Journal:  Pain Pract       Date:  2018-04-23       Impact factor: 3.183

6.  Prevalence and Cost Analysis of Chronic Pain After Hernia Repair: A Potential Alternative Approach With Neurostimulation.

Authors:  Aladine A Elsamadicy; Bilal Ashraf; Xinru Ren; Amanda R Sergesketter; Lefko Charalambous; Hanna Kemeny; Tiffany Ejikeme; Siyun Yang; Promila Pagadala; Beth Parente; Jichun Xie; Theodore N Pappas; Shivanand P Lad
Journal:  Neuromodulation       Date:  2018-10-15

7.  Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation.

Authors:  Fei Yang; Qian Xu; Bin Shu; Vinod Tiwari; Shao-Qiu He; Louis P Vera-Portocarrero; Xinzhong Dong; Bengt Linderoth; Srinivasa N Raja; Yun Wang; Yun Guan
Journal:  Pain       Date:  2016-11       Impact factor: 7.926

8.  Perioperative Opioid Consumption and Clinical Outcomes in Surgical Patients With a Pre-existing Opioid-Based Intrathecal Drug Delivery System.

Authors:  Ryan S D'Souza; Matthew A Warner; Oludare O Olatoye; Brendan J Langford; Danette L Bruns; Darrell R Schroeder; William D Mauck; Kalli K Schaefer; Nafisseh S Warner
Journal:  Anesth Analg       Date:  2022-01-01       Impact factor: 5.108

9.  The Use of Remote Programming for Spinal Cord Stimulation for Patients With Chronic Pain During the COVID-19 Outbreak in China.

Authors:  Yan Han; Yang Lu; Dengyu Wang; Mingshan Ran; Qidong Ren; Duo Xie; Tipu Z Aziz; Luming Li; James Jin Wang
Journal:  Neuromodulation       Date:  2021-03-22

Review 10.  Spinal Cord Stimulation for Treating Chronic Pain: Reviewing Preclinical and Clinical Data on Paresthesia-Free High-Frequency Therapy.

Authors:  Krishnan Chakravarthy; Hira Richter; Paul J Christo; Kayode Williams; Yun Guan
Journal:  Neuromodulation       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.